Strive Sports Medicine Physical Therapy, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 206 N Fruitland Blvd, Fruitland, MD 21826 Phone: 410-324-3301 Fax: 443-775-7728 |
News Archive
An international research team including scientists from the University of Cologne have identified a new mechanism for the development of Parkinson's disease, which could prove to be the starting point for the development of a more targeted therapy.
HHS inspector general Daniel Levinson in a report released on Wednesday questioned the legitimacy of a one-year research program conducted by CMS in which the federal government and Medicare beneficiaries paid oncologists a total of about $275 million to report information on chemotherapy side effects that might lead to improved care for cancer patients, the AP/South Florida Sun Sentinel reports.
Resverlogix Corp. announced today that it has officially activated the first site for the ASSURE 1 trial and commenced enrollment of patients for dosing of RVX-208. ASSURE 1 is the second Resverlogix Phase 2 clinical trial, led by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with acute coronary syndrome (ACS). This preparatory acute coronary syndrome study will ensure that 50 percent of the enrolled patients receive the IVUS (intravascular ultrasound) assessment.
Fear, anxiety, helplessness, anger - these are some of the often overwhelming feelings that people can encounter when dealing with cancer. When faced with a cancer diagnosis, knowledge is power. The Canadian Cancer Society empowers Canadians with timely cancer information so that people can make informed decisions about their health.
› Verified 9 days ago